New Findings in Batten Disease Drug Research
According to RUSH researchers, the FDA-approved lipid-lowering drug gemfibrozil may stop the progression of juvenile Batten disease. The Journal of
Read MoreAccording to RUSH researchers, the FDA-approved lipid-lowering drug gemfibrozil may stop the progression of juvenile Batten disease. The Journal of
Read MoreA symposium was presented at the 52nd Annual Meeting & Exhibition of the AADOCR, which was held in conjunction with
Read MoreThe first wearable sensor created by researchers at The Ohio State University is intended to detect and track muscle atrophy.
Read MoreResearch by Neeraj Agarwal, MD, called TALAPRO-2 showed that taking TALZENNA along with XTANDI can lower the risk of mortality
Read MoreResearchers from Weill Cornell Medical and the New York University Grossman School of Medicine found that the viral infection that
Read MoreA protein called TDP-43 is lost from its usual place in the cell nucleus in almost all individuals with amyotrophic
Read MoreScientists report that a novel approach to treating HIV that involves transplanting stem cells resistant to the virus from umbilical
Read MoreAccording to a Rutgers study, the criteria used by neurologists to evaluate for multiple sclerosis (MS) in adults may miss
Read MoreAccording to research from the Medical College of Georgia, 17% of women with unexplained infertility also have gene variations known
Read MoreAccording to the government, Tanzania has sent a team of medical professionals to investigate a mysterious illness that killed five
Read More